Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A clinician may review weight trend, glucose readings, blood pressure, hydration, bowel pattern, medication interactions, and lab results where appropriate
22, 2025 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the US
Provider-guided dosing adjustment based on your clinical response, tolerability, and metabolic biomarkers is the gold standard
Your body composition is key to your success and, your health
This chart is for informational purposes only and does not replace professional medical advice
Studies show that you could lose around 4% of your starting weight within the first month but it depends on your metabolism, age, diet, fitness levels, exercise routine and how your body responds to the treatment
US$ 21.87
US$ 27.56
US$ 20.23
US$ 25.66
US$ 28.60
